Welcome to our dedicated page for National Resh news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Resh stock.
National Research Corporation Common Stock (Delaware) (symbol: NRC) is dedicated to enhancing the experiences of patients, residents, and healthcare providers for over 35 years. Operating primarily in the United States and Canada, NRC Health provides analytics and insights that help healthcare organizations measure and improve patient and employee experiences, fostering greater engagement and loyalty.
NRC Health's offerings include a wide range of solutions that deliver value to its clients by enabling a deeper understanding of the individuals they serve. This holistic approach includes proprietary methods and tools that aid healthcare systems in designing experiences that build trust and inspire loyalty. These solutions are critical for healthcare providers, payers, and other organizations aiming to improve care delivery and patient outcomes.
In recent developments, NRC Health has partnered with LifeBridge Health, one of Maryland’s largest health systems, to implement the Human Understanding® program. This partnership, highlighted by NRC Health’s comprehensive data-driven insights and personalized healthcare solutions, aims to enhance patient care and satisfaction through innovative, human-centered approaches. The collaboration also involves administering the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey to ensure consistent quality measures.
Financially, NRC Health remains robust, drawing significant revenue from its United States operations. Its focused market research, patient-centered initiatives, and consumer preference data have earned NRC Health a top ranking for Patient Experience Improvement in the 2023 Best in KLAS report.
For more information about NRC Health, their services, or recent updates, visit www.nrchealth.com. You can also contact them at 800-388-4264 or via email at info@nrchealth.com.
National Research , dba NRC Health, (NASDAQ:NRC) announced first quarter 2024 results showing strong growth potential. The CEO highlighted the company's competitive edge in healthcare insights and innovative products. Financially, significant investments were made in technology and teams to support new product launches. The company returned $18 million to stockholders and focused on product innovation and growth investments.